United States of America
Mr. Hawkinson is an experienced financial executive with over 17 years of experience in the life sciences industry. Most recently, Mr. Hawkinson served as Chief Financial Officer of Theraclone Sciences, where he led all areas of finance, strategy, and corporate development. Prior to Theraclone, Mr. Hawkinson was Vice President, Finance and Accounting at CTI Biopharma, where he was responsible for SEC reporting, Treasury, and finance functions. Previously, Mr. Hawkinson was Vice President, Finance at Corixa Corporation, where he directed the finance and accounting functions, including all aspects of planning and reporting, operational accounting, and oversight of all SEC-related activities. Prior to Corixa, Mr. Hawkinson was an audit senior manager at Ernst & Young. Mr. Hawkinson earned his B.A. from the University of Washington and received his CPA in Washington State.